• Advanced Biomed completed an unregistered issuance of 270,000 common shares on April 30, 2026.
• Shares were issued to Xiaomin Chen in exchange for 100% equity interest in Acellent Technologies (Hong Kong).
• Consideration was valued at USD 1.08 million, based on USD 4 per share.
• Issuance relied on Securities Act exemption under Section 4(a)(2).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-051028), on May 01, 2026, and is solely responsible for the information contained therein.